Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans. [electronic resource]
Producer: 20110901Description: 85-92 p. digitalISSN:- 1524-4563
- Administration, Oral
- Adult
- Aged
- Blood Pressure -- drug effects
- Breast Neoplasms -- drug therapy
- Cells, Cultured
- Dose-Response Relationship, Drug
- Endothelium, Vascular -- drug effects
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neovascularization, Pathologic -- metabolism
- Nitric Oxide -- biosynthesis
- Piperidines -- administration & dosage
- Prospective Studies
- Quinazolines -- administration & dosage
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Tumor Cells, Cultured
- Vasodilation -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.